Inner Balance centers its hormone offering on Oestra, a prescription cream combining estradiol and progesterone for vaginal application. A single product may sound easier than managing separate medicines. The important next step is understanding what that combination is intended to do and what evidence supports your prescription.
This review checks Inner Balance’s public product and HRT pages, including their September 2026 pricing. We have not used Oestra or assessed an individual patient. We distinguish its advertised features from the clinical questions that require a prescriber’s answer.
One cream, with a systemic treatment claim
The Oestra treatment page describes a compounded combination intended for systemic hormone therapy. That distinction matters: a medicine placed in the vagina is not necessarily a low-dose local treatment. Route, ingredients and dose determine how a prescription is used.
If your main concern is dryness or painful sex, ask whether an approved local treatment would meet that need. If you also have hot flashes, ask how the proposed plan addresses them. Our vaginal versus systemic estrogen explainer can help you frame the discussion without assuming one cream replaces every other option.
Read the first six months separately
The product page advertises $199 per month for the first six months, followed by $99.50 per month. The lower ongoing figure is not the starting price. Ask how these monthly equivalents translate into actual charges, how much medicine each shipment contains and when the lower rate begins.
Budgeting should also account for what happens if the prescription changes. Ask whether a different strength requires another purchase and what support continues after a cancellation. A promotional guarantee should be read as a set of financial terms, not a promise that treatment carries no medical risk or will work for everyone.
Compounding is the central evidence question
Inner Balance identifies Oestra as compounded. That means the finished medicine does not have FDA approval. FDA approval of other estradiol or progesterone products does not transfer to a new combination, delivery system or concentration. Our compounding guide explains the distinction.
Ask the clinician why this preparation is appropriate for you compared with an approved option. Request evidence relevant to the actual combination and route, rather than evidence about estrogen treatment in general. A pharmacy badge or third-party testing claim can answer some manufacturing questions; it does not by itself establish long-term clinical benefits.
A specific conversation about the uterus
If you have a uterus, protecting its lining is an important part of systemic estrogen care. Ask how the prescribed progesterone amount and delivery method provide that protection, and what evidence supports the complete regimen. Do not assume that including progesterone in the ingredient list settles the question.
Also ask what bleeding changes should prompt evaluation, who would arrange that evaluation and whether an in-person examination might be needed. Keep a copy of the prescription and instructions. The progesterone and uterus article explains the purpose of this part of treatment without giving a dosing plan.
Ask which pharmacy will fill your order
The reviewed pages use different descriptions of pharmacy arrangements, including references to 503A and 503B facilities. We could not resolve the dispensing arrangement for an individual order from those pages. Ask for the pharmacy’s name and address, contact details, product label and instructions before medication is shipped.
This is especially useful when comparing a named compounded product with a manufactured brand. Find out how to report a damaged shipment, a dispenser problem or a suspected side effect. You should know which questions go to the pharmacy and which go to your clinician, without having to work it out after a problem occurs.
Keep convenience and outcomes separate
A simpler routine can be attractive, particularly if patches irritate your skin or several schedules are difficult to remember. That preference belongs in the consultation. It does not establish that a compounded cream is safer, more effective or suitable for every person who has trouble with another route.
The company publishes outcome and testimonial claims. We did not independently validate those results or establish a head-to-head advantage over approved HRT. Ask whether the evidence includes a comparison group, how long participants were followed and whether it applies to your age, medical history and reason for treatment.
Other reviews to bring into the decision
Compare Winona for another published compounded offering and Alloy for an approved patch option. MyMenopauseRx offers a different, visit-based route to discussing approved medicines with a pharmacy of your choice.
Inner Balance gives readers a clearly named product to investigate. The remaining work is prescription-specific: confirm the full price, pharmacy, rationale for compounding and monitoring plan. Use our appointment checklist to record those answers before deciding whether its single-product approach fits your needs.
FOLLOW THE EVIDENCE
Sources & further reading
Provider pages support service and price descriptions. Medical guidance supports treatment explanations. Neither is a first-hand review of patient outcomes. Checked September 20, 2026.